Institutions Holding Call Options on Arcus Biosciences, Inc. (RCUS)
This table provides information about the call option holders of Arcus Biosciences, Inc. (RCUS). We have compiled data on the institutions that hold call options on the stock, with a total of 3.3 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $66.3 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,772,500
calls
|
$35.6 Million
0.03% of portfolio
|
Q3 2025
Added 3.81%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
1,265,900
calls
|
$25.4 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
103,500
calls
|
$2.08 Million
0.0% of portfolio
|
N/A
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
93,900
calls
|
$1.88 Million
0.0% of portfolio
|
N/A
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
29,800
calls
|
$598,086
0.0% of portfolio
|
N/A
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Nov 14, 2025 Q3 2025 |
21,100
calls
|
$423,477
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
18,200
calls
|
$365,274
0.0% of portfolio
|
N/A
|